Amyloid precursor protein 17-mer peptide ameliorates hippocampal neurodegeneration in ovariectomized rats.

Neurosci Lett

Central Laboratory, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Disease of Ministry of Education, #45 Changchun Street, Xuanwu District, Beijing 100053, China.

Published: January 2010

Amyloid precursor protein 17-mer peptide (APP 17-mer peptide) is an active fragment of amyloid precursor protein (APP) in the nervous system that mediates various neuronal activities and functions. Estrogen deprivation during menopause disproportionately increases the risk of many neurodegenerative diseases, including Alzheimer's disease (AD). Currently, therapeutic approaches to treat Alzheimer's disease are less than effective. We have previously shown that APP 17-mer peptide participates in neuronal function in aged-hippocampal neurons. In this study, we investigate the effects of estrogen and APP 17-mer peptide on hippocampal neurodegeneration in ovariectomized rats. The results showed that decreases in learning and memory function in ovariectomized rats were associated with degenerative changes in hippocampal neurons. Estrogen deprivation also enhances apoptotic cell death and decreases expression of the anti-apoptotic protein Bcl-2. Administration of APP 17-mer peptide ameliorates changes associated with estrogen deprivation without affecting estrogen levels. These results indicate that APP 17-mer peptide may prevent neurodegeneration caused by estrogen deficiency. Our findings also suggest that estrogen deficiency-induced neurodegeneration is regulated by activation of an intracellular "cross talk" signaling pathway, connecting neurotrophins with APP 17-mer peptide.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2009.07.058DOI Listing

Publication Analysis

Top Keywords

17-mer peptide
32
app 17-mer
24
amyloid precursor
12
precursor protein
12
ovariectomized rats
12
estrogen deprivation
12
17-mer
8
protein 17-mer
8
peptide
8
peptide ameliorates
8

Similar Publications

A peptide derived from the amino terminus of leptin improves glucose metabolism and energy homeostasis in myotubes and db/db mice.

J Biol Chem

October 2024

Biochemistry and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. Electronic address:

Leptin is an adipokine, which plays key roles in regulation of glucose metabolism and energy homeostasis. Therefore, identification of a short peptide from leptin which improves glucose-metabolism and energy-homeostasis could be of significant therapeutic importance. Mutational studies demonstrated that N-terminal of human leptin hormone is crucial for activation of leptin-receptor while its C-terminal seems to have lesser effects in it.

View Article and Find Full Text PDF

H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration.

bioRxiv

July 2024

Section of Protein Structure and Function, Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health; Bethesda, MD, USA.

Photoreceptor death causes blinding inheritable retinal diseases, such as retinitis pigmentosa (RP). As disease progression often outpaces therapeutic advances, finding effective treatments is urgent. This study focuses on developing a targeted approach by evaluating the efficacy of small peptides derived from pigment epithelium-derived factor (PEDF), known to restrict common cell death pathways associated with retinal diseases.

View Article and Find Full Text PDF
Article Synopsis
  • Research on HIV-1 vaccines is focusing on conserved structural elements to target broadly neutralizing antibodies, particularly the D5 antibody which binds to a critical area on the viral gp41 protein.
  • Studies with different lengths of N-heptad repeat (NHR) peptides show that longer peptides can produce higher levels of neutralizing antibodies, indicating potential additional neutralizing areas beyond the D5 pocket.
  • The development of stabilized trimeric 51-mer peptides has shown promise in enhancing the immune response, resulting in better neutralization of HIV-1 compared to shorter peptides, highlighting the importance of peptide design in vaccine effectiveness.
View Article and Find Full Text PDF

There are numerous clinically proven methods for treating cancer worldwide. Immunotherapy has been used to treat cancer with significant success in the current studies. The purpose of this work is to identify somatically altered target gene neoantigens and investigate liver cancer-related immune cell interaction and functional changes for potential immunotherapy in future clinical trials.

View Article and Find Full Text PDF

A PEDF peptide mimetic effectively relieves dry eye in a diabetic murine model by restoring corneal nerve, barrier, and lacrimal gland function.

Ocul Surf

April 2024

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China; Department of Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, PA, 17033-0850, USA; Skyran Biologics Inc., Harrisburg, PA, USA, 17112. Electronic address:

Purpose: The study investigated effectiveness of a novel PEDF peptide mimetic to alleviate dry eye-like pathologies in a Type I diabetic mouse model established using streptozotocin.

Methods: Mice were treated topically for 3-6 weeks with Ppx (a 17-mer PEDF mimetic) 2x/day or vehicle. Corneal sensitivity, tear film, epithelial and endothelial injury were measured using Cochet-Bonnet esthesiometer, phenol red cotton thread wetting, fluorescein sodium staining, and ZO1 expression, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!